OVERVIEW

Advances In™ Personalizing MS Management Plans: Strategies for Optimizing Long-Term Patient Outcomes in MS and Individualizing Treatment within the S1P Receptor Modulator Class is organized by Physicians' Education Resource, LLC (PER).

Release Date: May 24, 2022
Expiration Date: May 24, 2023

Activity Overview:
This online educational activity is designed to provide expert interpretation of new and emerging data on the treatment of multiple sclerosis (MS) with a forward-looking perspective on how new and novel agents might impact clinical practice. The integration of biomarkers into diagnosis, the efficacy of various disease-modifying therapies with a focus on the sphingosine-1-phosphate receptor modulator (S1PRM) class, and patient-focused risk assessment are presented in a multimedia format, including a series of video interviews with expert thought leaders integrated into text-based elements.

Learning Objectives:
Upon successful completion of this activity, you should be better prepared to:
• Assess the role of potential biomarkers and other key indicators of multiple sclerosis (MS) related to early diagnosis of MS
• Evaluate the disease-modifying drug class of sphingosine 1-phosphate (S1P) receptor modulators for patients with MS regarding recent efficacy and safety data
• Discuss strategies to individualize management to optimize outcomes for patients with MS